NovoCure Ownership | Who Owns NovoCure?


OverviewForecastRevenueFinancialsChartTranscripts

NovoCure Ownership Summary


NovoCure is owned by 84.67% institutional investors, 9.81% insiders, and 5.52% retail investors. Fmr is the largest institutional shareholder, holding 14.99% of NVCR shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 7.08% of its assets in NovoCure shares.

NVCR Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockNovoCure84.67%9.81%5.52%
SectorHealthcare Stocks 487.91%11.08%-398.99%
IndustryMedical Instruments & Supplies Stocks57.81%14.56%27.62%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fmr16.23M14.99%$483.66M
Blackrock funding, inc. /de14.11M12.65%$251.24M
Blackrock12.13M11.31%$207.83M
Vanguard group11.80M10.90%$351.52M
Soleus capital management6.90M6.19%$122.90M
Capital world investors6.38M5.72%$113.61M
State street3.01M2.80%$51.49M
Geode capital management2.40M2.22%$71.54M
Balyasny asset management2.27M2.03%$40.41M
Price t rowe associates inc /md/1.68M1.56%$50.18M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Soleus capital management6.90M8.14%$122.90M
Invus financial advisors350.88K6.74%$6.01M
Palo alto investors lp962.40K3.64%$17.13M
Birchview capital, lp101.00K1.79%$1.80M
Nordwand advisors256.63K0.72%$4.57M
Granite investment partners604.04K0.52%$10.75M
Emerald advisers461.37K0.30%$8.21M
Washington capital management31.00K0.29%$400.52K
Deerfield management company, l.p. (series c)825.12K0.27%$14.69M
Emerald mutual fund advisers trust219.58K0.24%$3.91M

Top Buyers

HolderShares% AssetsChange
Blackrock12.13M0.00%3.05M
Soleus capital management6.90M8.14%1.38M
Capital world investors6.38M0.02%1.17M
Blackrock funding, inc. /de14.11M0.00%1.09M
American century companies1.03M0.01%959.08K

Top Sellers

HolderShares% AssetsChange
Capital investors---8.95M
Morgan stanley806.52K0.00%-950.12K
Price t rowe associates inc /md/1.68M0.01%-638.38K
Coatue management---608.67K
Baillie gifford1.16M0.03%-498.00K

New Positions

HolderShares% AssetsChangeValue
Point72 asset management470.00K0.02%470.00K$8.37M
Quantbot technologies lp74.16K0.03%74.16K$1.32M
Teacher retirement system of texas59.25K0.01%59.25K$1.77M
Hrt financial lp51.21K0.00%51.21K$911.00K
Ieq capital48.55K0.01%48.55K$864.17K

Sold Out

HolderChange
National bank of canada /fi/-2.00
Tfc financial management-3.00
Salem investment counselors-4.00
Pfg private wealth management-6.00
Brown brothers harriman-15.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20252474.22%94,464,090-0.79%841.14%12916.22%71-8.97%
Mar 31, 2025236-10.94%95,173,4933.94%861.21%110-14.06%782.63%
Dec 31, 20242495.51%88,494,339-4.72%811.11%11727.17%74-
Sep 30, 2024234-6.02%92,882,050-0.04%851.14%91-26.61%737.35%
Jun 30, 2024247-4.26%92,913,2194.09%861.23%123-1.60%676.35%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Growth Compy Commingled Pl S7.91M7.08%33.69K
Fidelity Growth Compy Commingled Pl O7.46M6.89%-
Fidelity Growth Company Fund5.44M4.86%-16.44K
American Funds SMALLCAP World A4.75M4.26%-3.59M
Vanguard US Total Market Shares ETF3.42M3.11%3.00K
Vanguard Total Stock Mkt Idx Inv3.37M3.01%-72.53K
American Funds Growth Fund of Amer A3.30M3.00%-5.51K
Capital Group Growth Fnd of Amer Comp3.30M2.96%-5.51K
Vanguard Small Cap Index2.57M2.30%-17.28K
iShares Russell 2000 ETF2.45M2.19%-

Recent Insider Transactions


DateNameRoleActivityValue
Sep 05, 2025Cordova Ashley Chief Executive OfficerBuy$996.86K
Jul 29, 2025Brackmann Christoph Chief Financial OfficerBuy$116.30K
Jul 29, 2025Brackmann Christoph Chief Financial OfficerBuy$58.00K
Jul 29, 2025Brackmann Christoph Chief Financial OfficerBuy$57.50K
Jun 03, 2025Stafford Kristin-Sell$17.26K

Insider Transactions Trends


DateBuySell
2025 Q33-
2025 Q2-12
2025 Q1-20
2024 Q4-4
2024 Q3-1

NVCR Ownership FAQ


Who Owns NovoCure?

NovoCure shareholders are primarily institutional investors at 84.67%, followed by 9.81% insiders and 5.52% retail investors. The average institutional ownership in NovoCure's industry, Medical Instruments & Supplies Stocks, is 57.81%, which NovoCure exceeds.

Who owns the most shares of NovoCure?

NovoCure’s largest shareholders are Fmr (16.23M shares, 14.99%), Blackrock funding, inc. /de (14.11M shares, 12.65%), and Blackrock (12.13M shares, 11.31%). Together, they hold 38.95% of NovoCure’s total shares outstanding.

Does Blackrock own NovoCure?

Yes, BlackRock owns 11.31% of NovoCure, totaling 12.13M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 207.83M$. In the last quarter, BlackRock increased its holdings by 3.05M shares, a 33.55% change.

Who is NovoCure’s biggest shareholder by percentage of total assets invested?

Soleus capital management is NovoCure’s biggest shareholder by percentage of total assets invested, with 8.14% of its assets in 6.9M NovoCure shares, valued at 122.9M$.

Who is the top mutual fund holder of NovoCure shares?

Fidelity Growth Compy Commingled Pl S is the top mutual fund holder of NovoCure shares, with 7.08% of its total shares outstanding invested in 7.91M NovoCure shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools